Onii S 125mg/250mg Injection
Marketer
Cellrox Life Sciences
Salt Composition
Ceftriaxone (125mg) + Sulbactam (250mg)
Overview Onii S 125mg/250mg Injection
Combiflox Injection (125mg/250mg) is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism involves inhibiting bacterial growth and proliferation. Administration must be solely under a physician's guidance; strict adherence to the prescribed dosage schedule is crucial. Complete the full course of treatment, even with symptom improvement, to prevent treatment failure. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms require immediate medical attention. Seek immediate help for allergic reactions like rashes, itching, swelling, or respiratory distress. Inform your doctor of all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impacting driving ability, refrain from driving if experiencing drowsiness or dizziness. Adequate rest, a balanced diet, and sufficient hydration are vital for optimal recovery. Your doctor might order tests to monitor the medicine's effects.
Primary Ingredients of Onii S 125mg/250mg Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Onii S 125mg/250mg Injection
Infections caused by bacteria
Major Benefits of Onii S 125mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Onii S 125mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Onii S 125mg/250mg Injection:
The medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Onii S 125mg/250mg Injection works:
Ceftriaxone and Sulbactam, combined as Onii S 125mg/250mg Injection, offer a dual-action approach to bacterial infections. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their growth and survival. Sulbactam, a beta-lactamase inhibitor, complements Ceftriaxone by neutralizing enzymes that bacteria use to resist antibiotic action, thus boosting its effectiveness.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of alcohol and Onii S 125mg/250mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Onii S (125mg/250mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; nevertheless, clinical data from human trials are scarce.
Breast feedingCAUTION
Administering Onii S 125mg/250mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Onii S 125mg/250mg Injection can induce drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data on Onii S 125mg/250mg Injection use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Individuals with severe hepatic impairment should use Onii S 125mg/250mg Injection cautiously, potentially requiring a modified dosage. Consult your physician for guidance. Dosage alteration for Onii S 125mg/250mg Injection is unnecessary in patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Onii S 125mg/250mg Injection :
Should you forget a scheduled dose of Onii S 125mg/250mg Injection, seek immediate medical advice.
Facts to Know About Onii S 125mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently